CRISM Therapeutics Corp Sustainability Reports
CRISM Therapeutics Corporation is a clinical-stage biotechnology company that develops implantable drug delivery technologies, such as ChemoSeed, to enhance the localized treatment of solid tumors. It also provides specialized pharmaceutical formulation development and consultancy services.
Sector: Manufacturing
Country: British Virgin Islands
Exchange: London Stock Exchange (AIM)
LEI: 213800XFW6MKVCHHPW88
FIGI: BBG001SN9TR4
2 reports from 2024 to 2025
